查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1224595

靜脈 (IV) 輸液泵市場規模、份額和趨勢分析報告：按產品（電容式、胰島素、注射器、腸內、門診）、疾病適應症、地區、細分市場預測，2023-2030 年

Intravenous Infusion Pump Market Size, Share & Trends Analysis Report By Product (Volumetric, Insulin, Syringe, Enteral, Ambulatory), By Disease Indication, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

靜脈 (IV) 輸液泵市場增長和趨勢

根據 Grand View Research, Inc. 的一份新報告預計，到 2030 年，全球靜脈 (IV) 輸液泵市場將達到 99 億美元，2023 年至 2030 年的複合年增長率為 8.3%。 專業化和智能化泵的引進和開發是輸液泵行業決定性增長的原因。 智能輸液泵被認為是市場的推動力，因為它們結合了錯誤減少軟件和定製藥物庫。 邁瑞醫療2018年的一項研究顯示，輸液泵是最傳統的醫院租賃設備。

心血管和癌症等新發疾病繼續推動對靜脈 (IV) 輸液泵設備的需求。 靜脈 (IV) 輸液泵可確保藥物和營養素的調節、控制和無差錯輸送。 當用化學療法和放射療法治療患者時，這些過程是必不可少的。 這些都是非常複雜的過程，需要非常精確的藥物劑量。 輸液泵設備創新、自動化和標準化劑量等因素的結合有望使患者的治療更加方便和用戶友好。

由於 COVID-19 大流行，2020 年靜脈 (IV) 輸液泵行業的需求出現增長。 這是因為輸液泵是最常用於突發衛生事件的醫療設備。 由於大流行病導致醫療設施使用量增加，對輸液泵等醫療設備的需求大幅飆升。 2020年5月，FDA還對輸液泵和輸液泵配件的緊急使用進行了全面授權。 醫療保健提供者的這種增加的使用響應了對輸液泵的增加的需求。

靜脈 (IV) 輸液泵市場報告要點

容量輸液泵已成為 2022 年最大的產品細分市場，原因是在緊急情況和化療等治療中越來越多地使用營養液和藥物等輸送流體

隨著全球糖尿病負擔的增加，預計胰島素輸注泵在預測期內的複合年增長率最高

隨著早產對最佳護理和營養需求的增加，兒科/新生兒領域在 2022 年的疾病適應症方面佔據市場主導地位

由於老年人口和糖尿病人口的增加，預計亞太地區在預測期內將經歷最快的增長

內容

第一章調查方法及範圍

  • 市場細分和範圍
    • 產品
    • 適應症
    • 區域範圍
  • 調查方法
  • 信息採購
    • 購買的數據庫
    • GVR 內部數據庫
    • 次要信息
    • 初步調查
  • 信息或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 模型詳細信息
    • 商品流分析（模型 1）
    • 批量價格分析（模型 2）
  • 二級信息列表
  • 主要信息列表
  • 目的

第 2 章執行摘要

  • 市場展望
  • 細分市場展望
  • 競爭考慮

第 3 章靜脈 (IV) 輸液泵市場變量、趨勢和範圍

  • 市場系列展望
    • 母公司市場展望
    • 相關/子公司市場前景
  • 市場動態
    • 市場驅動因素分析
    • 市場製約因素分析
    • 行業問題
  • 靜脈泵：市場分析工具
    • 行業分析 - 搬運工
    • PESTEL 分析
    • 對主要交易和戰略聯盟的分析
    • COVID-19 影響分析

第 4 章靜脈 (IV) 輸液泵市場：按產品細分分析，2018-2030 年（百萬美元）

  • 定義和範圍
  • 2018 年和 2030 年產品市場份額分析
  • 部門儀表板
  • 全球輸液泵市場，按產品分類，2022-2030 年
  • 以下2018-2030年市場規模及預測，趨勢分析
    • 按產品分類
      • 容量輸液泵
      • 胰島素輸注泵
      • 注射器輸液泵
      • 腸內輸液泵
      • 便攜式輸液泵
      • 患者自控鎮痛 (PCA)
      • 植入式輸液泵
      • 其他

第 5 章靜脈 (IV) 輸液泵市場：按疾病適應症細分分析，2018-2030（百萬美元）

  • 定義和範圍
  • 2022 年和 2030 年疾病適應症的市場份額分析
  • 部門儀表板
  • 按疾病適應症劃分的全球靜脈 (IV) 輸液泵市場，2018-2030 年
  • 以下2018-2030年市場規模及預測，趨勢分析
    • 化療
    • 糖尿病
    • 胃腸病學
    • 鎮痛和疼痛管理
    • 兒科和新生兒科
    • 血液學
    • 其他

第 6 章靜脈 (IV) 輸液泵市場：區域市場分析，按產品，2018-2030 年（百萬美元）

  • 定義和範圍
  • 2022 年和 2030 年區域市場份額分析
  • 區域市場儀表板
  • 區域市場概況
  • 2022 年區域市場份額
  • 2018-2030 年市場規模、預測和趨勢分析：
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞士
    • 俄羅斯
    • 瑞典
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳大利亞
    • 韓國
    • 馬來西亞
    • 印度尼西亞
    • 新加坡
    • 菲律賓
    • 泰國
    • 新西蘭
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 智利
  • 中東和非洲
    • 南非
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 以色列
    • 埃及

第 7 章靜脈 (IV) 輸液泵市場-競爭分析

  • 主要市場進入者的近期趨勢和影響分析
  • 公司/競爭對手分類（主要創新者、市場領導者、初創企業）
    • 參與公司
    • 創新者
  • 供應商情況
    • 主要服務提供商列表
      • 市場差異化因素
      • 輸液泵 - 市場份額分析
  • 主要公司介紹
    • 百特國際
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • B.Braun Melsungen AG
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • 美敦力
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • 麥克雷爾醫療器械公司
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • 費森尤斯·卡比
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • 波士頓科學公司
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • CAREFUSION 公司
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • 史密斯醫療
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • F. Hoffmann-La Roche Ltd.
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • Tandem Diabetes Care, Inc.
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • 泰爾茂公司
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • 邁瑞
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • 穆格公司
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • IRadimed 公司
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
Product Code: GVR-4-68038-560-1

Intravenous Infusion Pump Market Growth & Trends:

The global intravenous infusion pump market size is expected to reach USD 9.9 billion by 2030 and is expected to expand at 8.3% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. The introduction and development of specialty and smart pumps are responsible for the crucial growth of the infusion pump industry. Smart infusion pumps are considered an advancement that will give a boost to the market as it embeds error-reduction software and customized drug libraries. According to a study conducted by Mindray Medical company in 2018, infusion pumps are the most conventional hospital rental equipment.

The rise in diseases like cardiovascular and cancer continues to drive the demand for intravenous infusion pump devices. Intravenous infusion pumps ensure regulated, controlled, and error-free delivery of medications and nutrients. Such processes are essential while treating patients via chemotherapy or radiation therapy. These are very complex processes and require a very precise dosage of medication. The amalgamation of factors like shift in technology, automation, and standardized dosing for intravenous pump devices are anticipated to make therapy more convenient and user-friendly for patients.

The intravenous infusion pumps industry witnessed growth in demand in 2020 due to the COVID-19 pandemic. This was because infusion pumps are the most common medical devices used in health emergencies. As the pandemic burdened healthcare facilities due to increased use, the demand for medical devices like infusion pumps witnessed a major surge. In May 2020, the FDA also issued an umbrella authorization for the emergency use of infusion pumps and infusion pump accessories. This increased use by healthcare providers catered to the increased demand for infusion pumps.

Intravenous Infusion Pump Market Report Highlights:

  • Volumetric infusion pumps emerged as the largest product segment in 2022, owing to the increasing use of delivery fluids such as nutrients and medications during emergencies and treatments like chemotherapy
  • The insulin infusion pumps segment is projected to register the highest CAGR over the forecast period as the burden of diabetes increases globally
  • The pediatrics/ neonatology segment dominated the market in 2022 in terms of disease indication as there have been growing incidences of premature births, which require optimum care and nutrition
  • The Asia Pacific market is projected to witness the fastest growth over the forecast period owing to the increasing number of geriatric and diabetic patients in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Disease Indication
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Volume price analysis (Model 2)
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Intravenous Infusion Pumps Market Variables, Trends & Scope

  • 3.1. Market Lineage outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
    • 3.2.3. Industry Challenges
  • 3.3. Intravenous Infusion Pumps: Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. Major Deals & Strategic Alliances Analysis
    • 3.3.4. COVID-19 Impact Analysis

Chapter 4. Intravenous Infusion Pumps Market: Segment Analysis, by Product, 2018 - 2030 (USD Million)

  • 4.1. Definitions & Scope
  • 4.2. Product market share analysis, 2018 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Intravenous Infusion Pumps Market, by Product, 2022 to 2030
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. By product
      • 4.5.1.1. Volumetric Infusion pumps
      • 4.5.1.2. Insulin Infusion pumps
      • 4.5.1.3. Syringe Infusion pumps
      • 4.5.1.4. Enteral Infusion pumps
      • 4.5.1.5. Ambulatory Infusion pumps
      • 4.5.1.6. Patient Controlled Analgesia (PCA)
      • 4.5.1.7. Implantable Infusion pumps
      • 4.5.1.8. Others

Chapter 5. Intravenous Infusion Pumps Market: Segment Analysis, By Disease Indication, 2018 - 2030 (USD Million)

  • 5.1. Definitions & Scope
  • 5.2. Disease Indication market share analysis, 2022 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global Intravenous Infusion Pumps Market, By Disease Indication, 2018 to 2030
  • 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1. Chemotherapy
    • 5.5.2. Diabetes
    • 5.5.3. Gastroenterology
    • 5.5.4. Analgesia/Pain Management
    • 5.5.5. Pediatrics/Neonatology
    • 5.5.6. Hematology
    • 5.5.7. Others

Chapter 6. Intravenous Infusion Pumps Market: Regional Market Analysis, by Product, 2018 - 2030 (USD Million)

  • 6.1. Definitions & Scope
  • 6.2. Regional Market Share Analysis, 2022 & 2030
  • 6.3. Regional Market Dashboard
  • 6.4. Regional Market Snapshot
  • 6.5. Regional Market Share, 2022
  • 6.6. Market Size, & Forecasts, and Trend Analysis, 2018 to 2030:
  • 6.7. North America
    • 6.7.1. Market estimates and forecast, by country, 2018 - 2030 (USD Million)
    • 6.7.2. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
    • 6.7.3. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.7.4. U.S.
      • 6.7.4.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.7.4.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.7.5. Canada
      • 6.7.5.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.7.5.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
  • 6.8. Europe
    • 6.8.1. Market estimates and forecast, by country, 2018 - 2030 (USD Million)
    • 6.8.2. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
    • 6.8.3. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.8.4. Germany
      • 6.8.4.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.8.4.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.8.5. U.K.
      • 6.8.5.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.8.5.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.8.6. France
      • 6.8.6.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.8.6.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.8.7. Italy
      • 6.8.7.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.8.7.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.8.8. Spain
      • 6.8.8.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.8.8.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.8.9. Netherlands
      • 6.8.9.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.8.9.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.8.10. Belgium
      • 6.8.10.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.8.10.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.8.11. Switzerland
      • 6.8.11.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.8.11.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.8.12. Russia
      • 6.8.12.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.8.12.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.8.13. Sweden
      • 6.8.13.1 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.8.13.2 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
  • 6.9. Asia Pacific
    • 6.9.1. Market estimates and forecast, by country, 2018 - 2030 (USD Million)
    • 6.9.2. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
    • 6.9.3. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.9.4. China
      • 6.9.4.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.9.4.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.9.5. Japan
      • 6.9.5.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.9.5.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.9.6. India
      • 6.9.6.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.9.6.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.9.7. Australia
      • 6.9.7.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.9.7.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.9.8. South Korea
      • 6.9.8.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.9.8.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.9.9. Malaysia
      • 6.9.9.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.9.9.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.9.10. Indonesia
      • 6.9.10.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.9.10.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.9.11 Singapore
      • 6.9.11.1 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.9.11.2 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.9.12 Philippines
      • 6.9.12.1 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.9.12.2 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.9.13 Thailand
      • 6.9.13.1 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.9.13.2 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.9.14 New Zealand
      • 6.9.14.1 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.9.14.2 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
  • 6.10 Latin America
    • 6.10.1 Market estimates and forecast, by country, 2018 - 2030 (USD Million)
    • 6.10.2 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
    • 6.10.3 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.10.4 Brazil
      • 6.10.4.1 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.10.4.2 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.10.5 Mexico
      • 6.10.5.1 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.10.5.2 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.10.6 Argentina
      • 6.10.6.1 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.10.6.2 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.10.7 Colombia
      • 6.10.7.1 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.10.7.2 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.10.8 Chile
      • 6.10.8.1 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.10.8.2 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
  • 6.11 Middle East and Africa
    • 6.11.1 Market estimates and forecast, by country, 2018 - 2030 (USD Million)
    • 6.11.2 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
    • 6.11.3 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.11.4 South Africa
      • 6.11.4.1 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.11.4.2 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.11.5 Saudi Arabia
      • 6.11.5.1 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.11.5.2 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.11.6 UAE
      • 6.11.6.1 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.11.6.2 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.11.7 Israel
      • 6.11.7.1 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.11.7.2 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.11.8 Egypt
      • 6.11.8.1 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.11.8.2 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)

Chapter 7 Intravenous Infusion Pumps Market - Competitive Analysis

  • 7.1 Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2 Company/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
    • 7.2.1 Participant Categorization
    • 7.2.2 Innovators
  • 7.3 Vendor Landscape
    • 7.3.1 List of Key Service Providers
      • 7.3.1.1 Market Differentiators
      • 7.3.1.2 Intravenous Infusion Pumps- Market Share Analysis
  • 7.4 Key companies profiled
    • 7.4.1 Baxter International
      • 7.4.1.1 Company Overview
      • 7.4.1.2 Financial Performance
      • 7.4.1.3 Product Benchmarking
      • 7.4.1.4 Strategic Initiatives
    • 7.4.2 B. Braun Melsungen AG
      • 7.4.2.1 Company Overview
      • 7.4.2.2 Financial Performance
      • 7.4.2.3 Product Benchmarking
      • 7.4.2.4 Strategic Initiatives
    • 7.4.3 Medtronic
      • 7.4.3.1 Company Overview
      • 7.4.3.2 Financial Performance
      • 7.4.3.3 Product Benchmarking
      • 7.4.3.4 Strategic Initiatives
    • 7.4.4 Micrel Medical Devices Sa
      • 7.4.4.1 Company Overview
      • 7.4.4.2 Financial Performance
      • 7.4.4.3 Product Benchmarking
      • 7.4.4.4 Strategic Initiatives
    • 7.4.5 Fresenius Kabi
      • 7.4.5.1 Company Overview
      • 7.4.5.2 Financial Performance
      • 7.4.5.3 Product Benchmarking
      • 7.4.5.4 Strategic Initiatives
    • 7.4.6 Boston Scientific Corporation
      • 7.4.6.1 Company Overview
      • 7.4.6.2 Financial Performance
      • 7.4.6.3 Product Benchmarking
      • 7.4.6.4 Strategic Initiatives
    • 7.4.7 CAREFUSION CORPORATION
      • 7.4.7.1 Company Overview
      • 7.4.7.2 Financial Performance
      • 7.4.7.3 Product Benchmarking
      • 7.4.7.4 Strategic Initiatives
    • 7.4.8 Smiths Medical
      • 7.4.8.1 Company Overview
      • 7.4.8.2 Financial Performance
      • 7.4.8.3 Product Benchmarking
      • 7.4.8.4 Strategic Initiatives
    • 7.4.9 F. Hoffmann-La Roche Ltd.
      • 7.4.9.1 Company Overview
      • 7.4.9.2 Financial Performance
      • 7.4.9.3 Product Benchmarking
      • 7.4.9.4 Strategic Initiatives
    • 7.4.10 Tandem Diabetes Care, Inc.
      • 7.4.10.1 Company Overview
      • 7.4.10.2 Financial Performance
      • 7.4.10.3 Product Benchmarking
      • 7.4.10.4 Strategic Initiatives
    • 7.4.11 Terumo Corporation
      • 7.4.11.1 Company Overview
      • 7.4.11.2 Financial Performance
      • 7.4.11.3 Product Benchmarking
      • 7.4.11.4 Strategic Initiatives
    • 7.4.12 Mindray
      • 7.4.12.1 Company Overview
      • 7.4.12.2 Financial Performance
      • 7.4.12.3 Product Benchmarking
      • 7.4.12.4 Strategic Initiatives
    • 7.4.13 Moog Inc.
      • 7.4.13.1 Company Overview
      • 7.4.13.2 Financial Performance
      • 7.4.13.3 Product Benchmarking
      • 7.4.13.4 Strategic Initiatives
    • 7.4.14 IRadimed Corporation
      • 7.4.14.1 Company Overview
      • 7.4.14.2 Financial Performance
      • 7.4.14.3 Product Benchmarking
      • 7.4.14.4 Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Intravenous Infusion Pumps Market, By Region 2018 - 2030 (USD Million)
  • Table 4 Global Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 5 Global Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 6 North America Intravenous Infusion Pumps Market, By Country, 2018 - 2030 (USD Million)
  • Table 7 North America Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 8 North America Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 9 U.S. Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 10 U.S. Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 11 Canada Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 12 Canada Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 13 Europe Intravenous Infusion Pumps Market, By Country, 2018 - 2030 (USD Million)
  • Table 14 Europe Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 15 Europe Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 16 U.K. Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 17 U.K. Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 18 Germany Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 19 Germany Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 20 France Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 21 France Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 22 Italy Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 23 Italy Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 24 Spain Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 25 Spain Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 26 Netherlands Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 27 Netherlands Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 28 Belgium Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 29 Belgium Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 30 Switzerland Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 31 Switzerland Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 32 Russia Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 33 Russia Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 34 Sweden Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 35 Sweden Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific Intravenous Infusion Pumps Market, By Country, 2018 - 2030 (USD Million)
  • Table 37 Asia Pacific Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 38 Asia Pacific Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 39 India Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 40 India Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 41 Japan Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 42 Japan Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 43 China Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 44 China Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 45 Australia Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 46 Australia Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 47 South Korea Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 48 South Korea Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 49 Malaysia Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 50 Malaysia Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 51 Indonesia Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 52 Indonesia Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 53 Singapore Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 54 Singapore Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 55 Philippines Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 56 Philippines Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 57 Thailand Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 58 Thailand Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 59 Thailand Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 60 Thailand Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 61 Latin America Intravenous Infusion Pumps Market, By Country, 2018 - 2030 (USD Million)
  • Table 62 Latin America Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 63 Latin America Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 64 Brazil Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 65 Brazil Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 66 Mexico Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 67 Mexico Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 68 Argentina Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 69 Argentina Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 70 Colombia Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 71 Colombia Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 72 Chile Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 73 Chile Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 74 MEA Intravenous Infusion Pumps Market, By Country, 2018 - 2030 (USD Million)
  • Table 75 MEA Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 76 MEA Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 77 South Africa Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 78 South Africa Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 79 Saudi Arabia Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 80 Saudi Arabia Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 81 UAE Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 82 UAE Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 83 Israel Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 84 Israel Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 85 Egypt Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 86 Egypt Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Intravenous Infusion Pumps Market: Market snapshot
  • Fig. 8 Intravenous Infusion Pumps Market: Market segmentation
  • Fig. 9 Intravenous Infusion Pumps Market Strategy Framework
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Intravenous Infusion Pumps Market driver impact
  • Fig. 13 Intravenous Infusion Pumps Market restraint impact
  • Fig. 14 Intravenous Infusion Pumps Market Porter's Five Forces Analysis
  • Fig. 15 Intravenous Infusion Pumps Market PESTEL analysis
  • Fig. 16 Intravenous Infusion Pumps Market segment dashboard
  • Fig. 17 Intravenous Infusion Pumps Market: Product Movement Analysis
  • Fig. 18 Infusion pumps estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Intravenous Sets estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 IV cannulas estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Volumetric Infusion Pumps estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Insulin Infusion Pumps Market segment dashboard
  • Fig. 23 Intravenous Infusion Pumps Market: Disease Indication Movement Analysis
  • Fig. 24 Chemotherapy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Endocrinology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Diabetes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Gastroenterology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Analgesia/ Pain management market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Pediatrics/neonatology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Hematology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Global Intravenous Infusion Pumps Market: Regional movement analysis
  • Fig. 33 Global Intravenous Infusion Pumps Market: Regional outlook and key takeaways
  • Fig. 34 Global market share, by region
  • Fig. 35 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Netherlands market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Belgium market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Switzerland market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Russia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Malaysia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Indonesia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Singapore market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Philippines market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Colombia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Chile market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Middle East and Africa. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Israel market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 Egypt market estimates and forecast, 2018 - 2030 (USD Million)